Gravity Analytica

MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

MNKD 10.31.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-07

Name of Upcoming Event:MannKind Webcast

Full Press Release SEC Filings Our MNKD Tweets

About Gravity Analytica

Recent Filings

01.06.2025 - 8-K Current report

DANBURY, Conn.andWESTLAKE VILLAGE, Calif.,Oct. 31, 2024(GLOBE NEWSWIRE) --MannKind Corporation(Nasdaq: MNKD), announced today that its third quarter 2024 financial results will be released after market close onThursday, November 7, 2024.

MannKindwill host a webcast beginning at4:30 p.m. Eastern Timeto discuss the quarterly results and provide a business update. Participating in the conference call fromMannKindwill be Chief Executive OfficerMichael Castagna, PharmD, and Chief Financial OfficerChris Prentiss. The webcast will be accessible via a link on MannKind’s website athttps://investors.mannkindcorp.com/events-and-presentations. A replay will also be available in the same location within 24 hours following the call and be accessible for approximately 90 days.

AboutMannKindMannKind Corporation(Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.

We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication.

With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.

Please visitmannkindcorp.comto learn more, and follow us onLinkedIn,Facebook,XorInstagram.

ForMannKind:Investor RelationsAna Kapor(818) 661-5000Email:ir@mnkd.com

Media RelationsChristie Iacangelo(818) 292-3500Email:media@mnkd.com

Source: MannKind

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com